Clinical Trials Logo

Retinopathy of Prematurity clinical trials

View clinical trials related to Retinopathy of Prematurity.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT00870636 No longer available - Clinical trials for Retinopathy of Prematurity

Use of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)

Start date: n/a
Phase:
Study type: Expanded Access

The purpose of this study is to provide access to intravitreal injection of Avastin in high-risk infants who do not otherwise qualify for study NCT00702819, an investigational multi-site study examining Avastin use for retinopathy of prematurity.